These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 23159709

  • 1. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
    Qiao N, Wang K, Schlindwein W, Davies A, Li M.
    Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.
    Li M, Qiu S, Lu Y, Wang K, Lai X, Rehan M.
    Pharm Res; 2014 Sep; 31(9):2312-25. PubMed ID: 24590881
    [Abstract] [Full Text] [Related]

  • 3. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
    Hattori Y, Sato M, Otsuka M.
    J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
    [Abstract] [Full Text] [Related]

  • 4. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
    Sehić S, Betz G, Hadzidedić S, El-Arini SK, Leuenberger H.
    Int J Pharm; 2010 Feb 15; 386(1-2):77-90. PubMed ID: 19900519
    [Abstract] [Full Text] [Related]

  • 5. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z, Samy R, Sayeed VA, Khan MA.
    Pharm Dev Technol; 2012 Feb 15; 17(4):457-65. PubMed ID: 21265708
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I, Karki S, Shur J, Price R, Fotaki N.
    Int J Pharm; 2013 Sep 10; 453(2):380-8. PubMed ID: 23727143
    [Abstract] [Full Text] [Related]

  • 13. Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide.
    Rahman Z, Agarabi C, Zidan AS, Khan SR, Khan MA.
    AAPS PharmSciTech; 2011 Jun 10; 12(2):693-704. PubMed ID: 21598082
    [Abstract] [Full Text] [Related]

  • 14. Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.
    Sathisaran I, Dalvi SV.
    AAPS PharmSciTech; 2021 Jan 06; 22(1):29. PubMed ID: 33404968
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of sodium lauryl sulfate and tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour.
    Li M, Qiao N, Wang K.
    Pharmaceutics; 2013 Oct 11; 5(4):508-24. PubMed ID: 24300560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.